Literature DB >> 14624412

Hyperhomocysteinemia as a component of syndrome X.

Mor Oron-Herman1, Talma Rosenthal, Ben-Ami Sela.   

Abstract

Syndrome X, a cluster of several metabolic disorders that includes hyperinsulinemia, hypertriglyceridemia, and hypertension, is associated with severe vascular morbidity. Hyperhomocysteinemia is another risk factor for cardiovascular and cerebrovascular diseases, often exhibited by insulin-resistant patients. In the current study, we investigated the relationship between syndrome X and hyperhomocysteinemia in a rat model. Two groups of rats were fed either fructose-enriched diet or standard rat chow for 5 weeks. Systolic blood pressure (SBP), as well as fasting plasma insulin, triglycerides, total cholesterol, and total homocysteine levels, were determined at the beginning and at the end of the study. A complete metabolic syndrome was induced by the fructose-enriched diet, including hyperinsulinemia, hypertriglyceridemia, and hypertension. Homocysteine concentration was 72% higher after 5 weeks on the fructose diet (8.49 +/- 1.6 v 4.92 +/- 0.9 micromol/l, P<.01). Insulin, triglycerides, SBP, and homocysteine levels were insignificantly changed during 5 weeks on standard rat chow. Homocysteine was positively and significantly correlated with any original component of syndrome X (r=0.565, P=.014 with insulin, r=0.662, P=.001 with triglycerides, and r=0.774, P<.001 with SBP). The results of the present study indicate that hyperhomocysteinemia is an integral component of this rat model of syndrome X. It is thus highly likely that hyperhomocysteinemia is an integral component of the human syndrome X as well, and thereby contributes to the overall high vascular risk associated with this condition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624412     DOI: 10.1016/s0026-0495(03)00262-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  22 in total

1.  Homocysteine suppresses lipolysis in adipocytes by activating the AMPK pathway.

Authors:  Zhigang Wang; Maria Pini; Tong Yao; Zhanxiang Zhou; Changhao Sun; Giamila Fantuzzi; Zhenyuan Song
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-07-12       Impact factor: 4.310

2.  Plasma total homocysteine level and its association with carotid intima-media thickness in obesity.

Authors:  O Uysal; E Arikan; B Cakir
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

3.  Inhibitors of Ketohexokinase: Discovery of Pyrimidinopyrimidines with Specific Substitution that Complements the ATP-Binding Site.

Authors:  Bruce E Maryanoff; John C O'Neill; David F McComsey; Stephen C Yabut; Diane K Luci; Alfonzo D Jordan; John A Masucci; William J Jones; Marta C Abad; Alan C Gibbs; Ioanna Petrounia
Journal:  ACS Med Chem Lett       Date:  2011-04-18       Impact factor: 4.345

4.  Homocysteine inhibits adipogenesis in 3T3-L1 preadipocytes.

Authors:  Zhigang Wang; Xiaobing Dou; Tong Yao; Zhenyuan Song
Journal:  Exp Biol Med (Maywood)       Date:  2011-11-23

5.  Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome.

Authors:  Gideon R Hajer; Yolanda van der Graaf; Jobien K Olijhoek; Marianne C Verhaar; Frank L J Visseren
Journal:  Heart       Date:  2006-09-04       Impact factor: 5.994

6.  Prevalence of hyperhomocysteinemia during routine physical examination in Guangxi Province, China and related risk factors.

Authors:  Yuan-Yuan Qin; Peng Wang; Jin-Qiu Qin; Ai-Qiu Wei; Ping Huang; Zhan-Feng Lai; Fa-Quan Lin
Journal:  J Clin Lab Anal       Date:  2017-04-10       Impact factor: 2.352

7.  Folate deficiency is associated with oxidative stress, increased blood pressure, and insulin resistance in spontaneously hypertensive rats.

Authors:  Michal Pravenec; Viktor Kozich; Jakub Krijt; Jitka Sokolová; Václav Zídek; Vladimír Landa; Miroslava Simáková; Petr Mlejnek; Jan Silhavy; Olena Oliyarnyk; Ludmila Kazdová; Theodore W Kurtz
Journal:  Am J Hypertens       Date:  2013-01       Impact factor: 2.689

8.  The metabolic syndrome is not associated with homocysteinemia: the Persian Gulf Healthy Heart Study.

Authors:  I Nabipour; A Ebrahimi; S M Jafari; K Vahdat; M Assadi; A Movahed; F Moradhaseli; N Obeidi; Z Sanjdideh
Journal:  J Endocrinol Invest       Date:  2009-05       Impact factor: 4.256

Review 9.  Insulin resistance, metabolic stress, and atherosclerosis.

Authors:  Meghana Pansuria; Hang Xi; Le Li; Xiao-Feng Yang; Hong Wang
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

10.  Effect of taurine supplementation on hyperhomocysteinemia and markers of oxidative stress in high fructose diet induced insulin resistance.

Authors:  Hala O El Mesallamy; Ebtehal El-Demerdash; Lamiaa N Hammad; Hekmat M El Magdoub
Journal:  Diabetol Metab Syndr       Date:  2010-06-30       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.